Light therapy for glioblastoma using yellow fluorescence
Part of Cancer clinical trials.
This trial tests a light-activated treatment for glioblastoma (a fast-growing brain tumor). A special drug is given that makes the tumor glow yellow, then light is used to destroy the cancer cells while protecting healthy brain tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with glioblastoma, a type of brain cancer.
- Your tumor may be new (just found) or come back after treatment. It can be a single spot or multiple spots.
- You cannot be allergic to photosensitizers—medicines that make your skin and eyes sensitive to light.
- You must not have a severe bleeding disorder or serious heart or blood vessel problems.
- You must not be pregnant or breastfeeding, and you must agree to the study rules by signing a consent form.
- You must not have other types of brain tumors or diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach that uses a light-sensitive drug and low-intensity ultrasound to make standard chemotherapy more effective for glioblastoma. If you have completed initial treatment with radiation and temozolomide without the tumor growing, you may be eligible.
This study tests whether using special fluorescent dye during brain tumor surgery, combined with chemotherapy and radiation, helps the body's immune system fight glioblastoma (an aggressive brain cancer). Researchers will track immune markers in your blood over time to understand how these treatments work together.
This trial tests a special fluorescent dye (FG001) that helps surgeons see and remove high-grade brain tumors more completely during surgery. The dye is injected before surgery and glows under special light, potentially helping surgeons remove more tumor tissue safely.
This study tests a light-activated therapy (radiodynamic therapy) using a special medicine to help treat a brain tumor that has come back after prior treatment. It may be offered after doctors decide you need further radiation for your recurrence.
This trial is testing whether a drug called G-CSF (which helps boost white blood cells) can help people with glioblastoma who are already receiving standard treatment with radiation and chemotherapy (temozolomide). It aims to see if G-CSF can reduce side effects and improve outcomes.
This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.
Hear when a new Glioblastoma Multiforme (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.